Volume 16, Issue 8, Pages (August 2019)

Slides:



Advertisements
Similar presentations
1 A review of the safety of Moxifloxacin Hydrochloride Leonard Sacks MD Medical officer/DSPIDP.
Advertisements

Date of download: 6/17/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Morphology of the QT Interval Predicts Torsade.
Volume 14, Issue 10, Pages (October 2017)
Thomas F. O’Donnell, MD, Joseph Lau, MD  Journal of Vascular Surgery 
Volume 7, Issue 1, Pages (January 2010)
Volume 8, Issue 9, Pages (September 2011)
Volume 13, Issue 11, Pages (November 2016)
Volume 13, Issue 2, Pages (February 2016)
Canadian Cardiovascular Society and Canadian Pediatric Cardiology Association Position Statement on the Approach to Syncope in the Pediatric Patient 
Volume 10, Issue 1, Pages (January 2013)
Volume 11, Issue 1, Pages (January 2014)
Volume 9, Issue 7, Pages (July 2012)
Volume 13, Issue 1, Pages (January 2016)
Volume 13, Issue 1, Pages (January 2016)
Volume 9, Issue 7, Pages (July 2012)
Volume 8, Issue 11, Pages (November 2011)
Holiday Heart Block: Alcohol-induced PR Prolongation
Inherited Arrhythmias: Of Channels, Currents, and Swimming
Volume 11, Issue 1, Pages (January 2014)
Thomas F. O’Donnell, MD, Joseph Lau, MD  Journal of Vascular Surgery 
Sinus bradycardia and chronotropic incompetence associated with single-agent itraconazole antifungal therapy: A case report  Julian Tokarev, BS, David.
Howell S.J. , Sear J.W. , Foëx P   British Journal of Anaesthesia 
Blockade of nociceptive sensory afferent activity of the rat knee joint by the bradykinin B2 receptor antagonist fasitibant  A. Gomis, S. Meini, A. Miralles,
Vincent B. McGinty, Antonio Rangel, William T. Newsome  Neuron 
Potential diagnostic utility of intermittent administration of short-acting gonadotropin- releasing hormone agonist in gonadotropin deficiency  Carrie.
Volume 111, Issue 2, Pages (July 2016)
Volume 13, Issue 2, Pages (February 2016)
Volume 13, Issue 5, Pages (May 2016)
Jianing Yu, David Ferster  Neuron 
Volume 14, Issue 11, Pages (November 2017)
A Smartphone App Reveals Erratic Diurnal Eating Patterns in Humans that Can Be Modulated for Health Benefits  Shubhroz Gill, Satchidananda Panda  Cell.
Therapeutic application of contrast-enhanced ultrasound and low-dose urokinase for thrombolysis in a porcine model of acute peripheral arterial occlusion 
Genotype-phenotype-guided medical and surgical intervention in long QT syndrome  Robyn J. Hylind, MS, CGC, Virginie Beausejour Ladouceur, MD, Francis Fynn-Thompson,
Volume 4, Issue 2, (February 2007)
Volume 5, Issue 2, Pages (February 2008)
Attenuation of high-frequency (30–200 Hz) thalamocortical EEG rhythms as correlate of anaesthetic action: evidence from dexmedetomidine  G. Plourde, F.
Normalization of QT interval duration in a long QT syndrome patient during pregnancy and the postpartum period due to sex hormone effects on cardiac repolarization 
Novel CALM3 mutations in pediatric long QT syndrome patients support a CALM3- specific calmodulinopathy  Marie-A. Chaix, MD, MSc, Tamara T. Koopmann, PhD,
T-wave oversensing during drug challenge test after subcutaneous implantable cardioverter-defibrillator implantation in a patient with Brugada syndrome 
Peter Janssen, Rufin Vogels, Yan Liu, Guy A Orban  Neuron 
Use of topical lidocaine in eliminating mechanically stimulated ventricular fibrillation in a patient with short QT syndrome  Maria J. Farag, BS, Joseph.
Volume 9, Issue 2, Pages (February 2012)
HeartRhythm Case Reports
Reduced pleural drainage, length of stay, and readmissions using a modified Fontan management protocol  Nancy A. Pike, PhD, Carol A. Okuhara, MN, Joy.
Mosquitoes Use Vision to Associate Odor Plumes with Thermal Targets
Volume 95, Issue 5, Pages e5 (August 2017)
Atrial pacing for the management of ventricular arrhythmias in Andersen-Tawil syndrome  Opeyemi Fadahunsi, MBBS, MPH, Bilal Shaikh, DO, Andrew Rettew,
Serotonergic Modulation of Intrinsic Functional Connectivity
Flecainide treats a novel KCNJ2 mutation associated with Andersen-Tawil syndrome  Hanora A. Van Ert, BSN, Elise C. McCune, Kate M. Orland, MS, Kathleen.
Evolution of treatment options and outcomes for hypoplastic left heart syndrome over an 18-year period  Tara Karamlou, MD, Brian S. Diggs, PhD, Ross M.
Volume 7, Issue 3, Pages (March 2010)
Michael R. Gold, MD, PhD, FHRS  Heart Rhythm 
A novel CACNA1C mutation identified in a patient with Timothy syndrome without syndactyly exerts both marked loss- and gain-of-function effects  Junichi.
A Smartphone App Reveals Erratic Diurnal Eating Patterns in Humans that Can Be Modulated for Health Benefits  Shubhroz Gill, Satchidananda Panda  Cell.
Kevin M. W. Leong, MBBS, MRCP, Henry Seligman, MBBS, MRCP, Amanda M
Keith Suarez, MD, Ryan Mack, MD, Evan L
Volume 9, Issue 1, Pages (January 2012)
Dynamic QT Interval Changes from Supine to Standing in Healthy Children  Audrey Dionne, MD, Anne Fournier, MD, Nagib Dahdah, MD, Dominic Abrams, MD, Paul.
An unusual cause of HV prolongation
Volume 24, Issue 8, Pages e6 (August 2018)
Dexamethasone suppresses long QT phenotype in patient with acute promyelocytic leukemia treated with arsenic  Jeffrey R. Winterfield, MD, FHRS, David.
A Strategy for Conversion From Subcutaneous to Oral Ketamine in Cancer Pain Patients: Effect of a 1:1 Ratio  Miguel Angel Benítez-Rosario, MD, PhD, Antonio.
Annika Winbo, MD, PhD, Annika Rydberg, MD, PhD 
P wave and the development of atrial fibrillation
Volume 9, Pages (November 2018)
Volume 29, Issue 3, Pages e4 (February 2019)
Use Dependence of Heat Sensitivity of Vanilloid Receptor TRPV2
Prolonged QT Syndrome: Perioperative Management
Inherited Arrhythmias: Of Channels, Currents, and Swimming
George D. Dickinson, Ian Parker  Biophysical Journal 
Presentation transcript:

Volume 16, Issue 8, Pages 1141-1148 (August 2019) Grapefruit juice prolongs the QT interval of healthy volunteers and patients with long QT syndrome  Ehud Chorin, MD, PhD, Aviram Hochstadt, MD, Yoav Granot, MD, Shafik Khoury, MD, Arie Lorin Schwartz, MD, Gilad Margolis, MD, Rami Barashi, MD, Dana Viskin, MD, Eihab Ghantous, MD, Michael Schnapper, MD, Tal Mekori, MD, Dana Fourey, MD, Milton Ernesto Guevara-Valdivia, MD, Manlio F. Marquez, MD, David Zeltzer, MD, Raphael Rosso, MD, Sami Viskin, MD  Heart Rhythm  Volume 16, Issue 8, Pages 1141-1148 (August 2019) DOI: 10.1016/j.hrthm.2019.04.039 Copyright © 2019 Heart Rhythm Society Terms and Conditions

Figure 1 Design of the thorough QT study. Consented patients were hospitalized twice, 1 week apart, each time for 2 days (period 1 [day 1–2] and period 2 [day 3–4]). Every day started with 3 electrocardiograms (ECGs), recorded 30 minutes apart, defined as baseline ECG of the day. The first day of each hospitalization period (day 1 and day 3) were dedicated to record repeated ECGs (at hourly intervals) without any drug intervention, defined as off-drug ECGs. Patients were randomized to moxifloxacin or grapefruit on day 2. The alternative drug was tested on day 4. The doses used were (1) a single dose of moxifloxacin 400 mg and (2) grapefruit juice (1 L after the baseline ECGs and 2 doses of 0.5 L 4 and 6 hours later. Patients with long QT syndrome underwent baseline and off-drugs ECG recordings on day 1 and then baseline followed by grapefruit on day 2. Heart Rhythm 2019 16, 1141-1148DOI: (10.1016/j.hrthm.2019.04.039) Copyright © 2019 Heart Rhythm Society Terms and Conditions

Figure 2 QT prolongation after drinking grapefruit juice in a patient with long QT syndrome. Electrocardiogram (ECG) during maximal QT prolongation after the ingestion of grapefruit juice (bottom trace) and off-drug at the same time 1 day previously (top trace). Both traces are from a 61-year-old male patient with long QT syndrome type 1 treated with β-blockers. Note that despite a similar heart rate (46 beats/min vs 48 beats/min), the QT interval is longer after grapefruit administration. This rate-corrected QT (QTc) prolongation >500 ms by grapefruit led to a change in the study protocol: Subsequent patients with long QT syndrome received only 2 doses of grapefruit juice instead of the 3 doses given to healthy controls. Heart Rhythm 2019 16, 1141-1148DOI: (10.1016/j.hrthm.2019.04.039) Copyright © 2019 Heart Rhythm Society Terms and Conditions

Figure 3 Deviations of the rate-corrected QT (QTc) interval from baseline during different study days with different interventions. All graphs depicted mean with 95% confidence interval. For all panels, delta QTc represents the change in QTc interval from the baseline QTc interval of that particular day, where the baseline QTc interval represents the average QTc interval obtained from 3 electrocardiograms (ECGs) recorded 30 minutes apart before any intervention. The horizontal axis shows the time (in hours) starting after the third baseline ECG. The vertical axis represents changes in the QTc interval (either prolongation or shortening) from baseline (or delta QTc) after a given intervention. Note the different scales in the vertical axis for each panel in this figure. The yellow arrow denotes the timing of administration of oral moxifloxacin after the third baseline electrocardiogram and the pink and red arrows denote repeated administration of grapefruit juice. The symbols denote that the delta QTc from baseline after a given intervention is different from the delta QTc from baseline of the off-drug day at the same time, with the following statistical significance: *P < .05, ‡P < .01, and §P < .001. A: Comparison of delta QTc during the off-drug day before moxifloxacin (in green) and during the off-drug day before grapefruit (in blue). Note that the 2 graphs are similar, never reaching a statistically significant difference. B and C: Delta QTc in healthy volunteers after receiving moxifloxacin (yellow line) or grapefruit (red line) and delta QTc during their respective off-drug study day. D: Delta QTc of patients with long QT syndrome after drinking grapefruit juice (pink line) and during the off-drug day (light green). LQT = long QT. Heart Rhythm 2019 16, 1141-1148DOI: (10.1016/j.hrthm.2019.04.039) Copyright © 2019 Heart Rhythm Society Terms and Conditions

Figure 4 A: Maximal rate-corrected QT (QTc) prolongation after the different interventions. The colored boxes represent the interquartile range (25th–75th percentiles) for the individual maximal QTc prolongation after each intervention. The thick black line in the box denotes the 50th percentile, and bars represent the range of results excluding outliers. Circles indicate outliers. The symbol *** denotes that the difference between the maximal QTc prolongation after moxifloxacin ingestion and that after grapefruit ingestion in healthy volunteers or after grapefruit ingestion in patients with long QT syndrome is different (P < .001) from the maximal QTc prolongation (with respect to their baseline value) during off-drug study days. B: Percentage of patients reaching a QTc prolongation (with respect to their baseline value) at least once after an intervention. Colored columns represent actual values, and bars represent 95% confidence intervals. Note that in 40% of patients with long QT syndrome, the QTc interval increased by ≥40 ms after drinking grapefruit juice. Heart Rhythm 2019 16, 1141-1148DOI: (10.1016/j.hrthm.2019.04.039) Copyright © 2019 Heart Rhythm Society Terms and Conditions